Key Aspects of the WHO Guidelines
- Unified Management: The guidelines provide integrated, evidence-based recommendations for clinical management, ensuring consistent care for patients with dengue, chikungunya, Zika, and yellow fever.
- Early Detection & Response: Strengthening surveillance systems and promoting integrated vector management are key to early detection of cases and outbreaks.
- Integrated Vector Management: The guidelines support a comprehensive approach to controlling mosquito populations through community participation, biological and chemical control, and environmental management.
- Integrated Vector Management: The guidelines support a comprehensive approach to controlling mosquito populations through community participation, biological and chemical control, and environmental management.
Explanation of Exam Oriented Key Terms
01Arboviral Diseases |
| Arboviral diseases are viral infections transmitted to humans through the bite of infected arthropods (insects). The term “arbovirus” is a portmanteau for arthropod-borne viruses. Primarily transmitted by arthropods such as mosquitoes and ticks, these viruses cause up to 700,000 deaths annually. The World Health Organization’s (WHO) Global Arbovirus Initiative was launched to address this epidemic and pandemic potential About Arboviral Viruses
Major Arboviral Diseases
Symptoms and Progression
Diagnosis and Treatment
Impact of Climate Change
Prevention and Control
|
PRACTICE QUESTIONS
With reference to the World Health Organization (WHO) 2025 guidelines on the clinical management of arboviral diseases, consider the following statements:
I. This is the first time that the WHO has published a unified global guideline covering the clinical management of dengue, chikungunya, Zika, and yellow fever
II. The guidelines recommend specific antiviral treatments for all four diseases to prevent severe illness, particularly in resource-limited settings
III. The need for an integrated approach is emphasized because these diseases often present with similar early symptoms and can circulate simultaneously in the same region, making differential diagnosis challenging
How many of the statements given above is/are correct?
a) Only one
b) Only two
c) All three
d) None
Answer: b
Explanation: Statement I is correct: The WHO released its first-ever integrated guidelines for the clinical management of patients with suspected or confirmed arboviral diseases (dengue, chikungunya, Zika, and yellow fever) in July 2025. This is the first time the organization has published a single global guideline covering all four diseases. Statement II is incorrect: Currently, there are no specific antiviral treatments available for these diseases. Management focuses on supportive care, and no vaccines are yet available for all of them (e.g., no specific vaccine for chikungunya or Zika). The guidelines aim to standardize evidence-based protocols for managing both mild and severe cases using existing methods. Statement III is correct: A key rationale for the integrated guidelines is the diagnostic challenge posed by the overlapping initial symptoms of these diseases. In many tropical and subtropical regions, multiple arboviruses may circulate at the same time, making clinical differentiation difficult, especially where diagnostic testing is limited. The guidelines support healthcare providers in making clinical judgments despite these challenges.
